soooooo roughly 10 dolla per share per billion....1 billion 10 dolla..2 billion 20 dolla,,,,,3 billion 30 dolla....4 billion 40 dolla....and so on......i can live with that kind of outcome on a 25 cent bet.....LOL
Excellent post AMG. Well said in black and white for all to see using real life facts. You can't put a valuation on how valuable NP-120 really is. Because in a post COVID 19 world the rights to this drug is like owning a large, rare and precious jewel. One that may even start a bidding war amongst big pharma.
You actually had a really interesting theory on one of your older posts. In that Ifenprodil may have been the drug that Sanofi let slip away from their grasp years ago and now with this pandemic that hydroxy-whatever drug was just a vein attempt to sell some pills. If they still owned the rights to Ifenprodil this is the drug they would in fact be pushing to the forefront. But alas Algernon holds the keys and now we wait for the flowers to bloom.
"We've been speaking to regulatory consultants that sort of suggest that if mortality was an endpoint and you showed statistical significance improvement on that - that might be an instantly approvable endpoint.
So you would actually get conditional sale of drug to treat the condition."
Great points being presented today. I lean towards the Licensing or selling rights to NP-120 and then still having a $B market cap with a future in this apparently lucrative concept from Dr. Moreau...BTH>NASH>AGN...GLTA...
To those trying for an extra penny lower or squeaking out to several digits past $.30+, my opinion is anything bought now will be worth more soon and possibly hugely more. Us long timers are helping maintain because we believe.